Drug Development for Multidrug-Resistant Bacteria: Why Compromise?

Mical Paul*, Leonard Leibovici

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)508-509
Number of pages2
JournalJournal of Infectious Diseases
Volume217
Issue number3
DOIs
StatePublished - 17 Jan 2018

Cite this